Page 2 - Buzzing Stock

Bulk deal impact: Bectors Food zooms 17% as Abakkus Investment buys stake

Today's rally came after Abakkus Investment Managers Pvt Ltd, owned by ace investor Sunil Singhania, acquired 29,39,588 shares of Mrs Bectors Food Specialities through a bulk deal.

MRPL soars 13% on strong Q1 result; analyst suggests buying on breakout

As per NSE data, MRPL shares have outperformed the Nifty 50 index over the past year, having gained 19.24 per cent.

J&K Bank soars 6% as lender to divest PNB MetLife stake; stock up 80% YTD

J&K Bank has proposed to divest 10.25 million equity shares in PNB MetLife India Insurance Company at ₹117.20 apiece, taking the transaction value to ₹120.1 crore.

Mukul Agrawal portfolio stock Hind Rectifiers zooms 19%, hits new high

According to the shareholding data, ace investor Mukul Agrawal held 1.45 equity stake in Hind Rectifiers as of March 2026.

Fino Payments Bank zooms 13% on strong June business update

Fino Payments Bank share price jumped 13 per cent on Monday after the company announced its business performance for June.

Voltas jumps over 4% as company hikes AC prices with immediate effect

As per reports, Voltas has increased prices across the RAC portfolio by 2.5 per cent to 3 per cent.

Dixon-Vivo JV receives much-awaited nod; Nomura sees modest upside in stock

Dixon Technologies today was up 4 per cent intraday as the company secured government approval to set up its joint venture (JV) with Vivo Mobile India (VMI).

Apollo Micro jumps 5% on agreement to buy 41.3% stake in Premier Explosives

Apollo Micro shares gained 5 per cent after approval was granted to the company to acquire 41.3 per cent stake in Premier Explosives.

Indus Towers shares gain 3% after Nomura reiterates 'Buy'; sees 30% upside

Nomura has maintained a 'Buy' rating on Indus Towers. The brokerage has kept its target price unchanged at ₹505, implying an upside of 30 per cent from its previous close of ₹388.55.

Piramal Pharma shares rise 4% on successful closure of US FDA inspection

Piramal Pharma said that the US FDA has issued an Establishment Inspection Report (EIR) for its Sellersville facility, and the inspection has now been successfully closed.

Natco Pharma gains nearly 3% on ₹2,500 crore South Africa investment plan

Natco Pharma has announced investments of nearly ₹2,500 crore in South Africa, including infusing ₹1,400 crore in its arm in the country with an aim to enter new geographies.

RCF shares jump 5% as board approves ₹1,500 crore FPO plan

RCF has informed that its board has approved plans to raise funds by way of a "Further Public Offering through a fresh issue of equity shares by the company aggregating up to ₹1,500 crore".

Supriya Lifescience tanks 12%; what's ailing this pharma stock?

Supriya Lifescience said proceedings were initiated against the personnel of the company under the NDPS Act, 1985 for a procedural lapse for a single export transaction of an identified producer.

Jagsonpal Pharma rallies 14% on acquisition update; time to book profit?

Jagsonpal Pharmaceuticals has entered into a definitive agreement to acquire an 85 per cent equity stake in Aequitas Healthcare

Netweb Technologies tanks 10%; what's dragging this multibagger stock?

Analysts said that today's correction in Netweb Technologies appears to be driven by announcement that its board will consider a fund-raising proposal, raising concerns over potential equity dilution.

Omaxe soars 20% on launch of dedicated hospitality arm, to invest ₹6200-cr

Omaxe Ltd has announced that the dedicated hospitality business vertical will develop 19 hotels spread over nearly 5 million sq. ft. across five states in the next 4-5 years.

Rajesh Exports falls 5%, hits lower circuit for 2nd day after ED action

ED's action came against Rajesh Exports in the backdrop of Sebi's allegation of a massive financial fraud in the company.

Urban Company gains 7% on huge volume; stock up 45% from March low

Urban Company stock price: The average trading volume at the counter more-than-doubled with a combined 14.13 million shares changing hands on the NSE and BSE in Monday's trade.

Premier Explosives zooms 52% in 1 month; what's behind the rally?

In the past six months, the stock price of the company surged 78 per cent, as compared to 10 per cent decline in the BSE Sensex.

IFCI tanks 10% on huge volume after massive 102% surge from March low

In the past two trading days, IFCI's stock price corrected 16% from its 52-week high amid profit booking after the NSE filed the DRHP for its long-awaited IPO.